Difference between revisions of "Part:BBa C0083:Experience"
Franksargent (Talk | contribs) (→User Reviews) |
|||
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | ||
Line 7: | Line 6: | ||
===User Reviews=== | ===User Reviews=== | ||
− | <!-- DON'T DELETE --><partinfo> | + | <!-- DON'T DELETE --><partinfo>BBa_K190019 StartReviews</partinfo> |
− | + | ||
{|width='80%' style='border:1px solid gray' | {|width='80%' style='border:1px solid gray' | ||
|- | |- | ||
|width='10%'| | |width='10%'| | ||
− | <partinfo> | + | <partinfo>BBa_K190019 AddReview 2</partinfo> |
− | <I> | + | <I>iGEM Groningen 2009</I> |
|width='60%' valign='top'| | |width='60%' valign='top'| | ||
− | + | ||
− | |}; | + | The capacity of fMT to enhance the arsenite accumulation in ''E. coli'' was tested using an arsenite uptake [http://2009.igem.org/Team:Groningen/Protocols assay]. But unfortunately the arsenic concentration determined by ICP-MS was not reproducible and did not show enhanced arsenite accumulation in ''E. coli'' carrying fMT (induced by lactose). |
+ | |} | ||
+ | ; | ||
+ | <!-- End of the user review template --> | ||
+ | |||
+ | {|width='80%' style='border:1px solid gray' | ||
+ | |- | ||
+ | |width='10%'| | ||
+ | <partinfo>BBa_K190019 AddReview 3</partinfo> | ||
+ | <I>iGEM Dundee 2011</I> | ||
+ | |width='60%' valign='top'| | ||
+ | |||
+ | We found the sequence of this part to be correct as listed and modified it by the addition of a microcompartment targeting domain and an HA epitope tag (as <partinfo>K562018</partinfo>). This will allow better monitoring of production of the protein. Indeed, we could detect production of this fusion in <i>E. coli</i> using an anti-HA monoclonal antibody. We did not get the chance to test arsenic resistance in a host cell producing this part. | ||
+ | |} | ||
+ | ; | ||
<!-- End of the user review template --> | <!-- End of the user review template --> | ||
− | <!-- DON'T DELETE --><partinfo> | + | <!-- DON'T DELETE --><partinfo>BBa_K190019 EndReviews</partinfo> |
Revision as of 15:39, 21 September 2011
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_C0083
User Reviews
UNIQafaeea44a76f2942-partinfo-00000000-QINU
••
iGEM Groningen 2009 |
The capacity of fMT to enhance the arsenite accumulation in E. coli was tested using an arsenite uptake [http://2009.igem.org/Team:Groningen/Protocols assay]. But unfortunately the arsenic concentration determined by ICP-MS was not reproducible and did not show enhanced arsenite accumulation in E. coli carrying fMT (induced by lactose). |
•••
iGEM Dundee 2011 |
We found the sequence of this part to be correct as listed and modified it by the addition of a microcompartment targeting domain and an HA epitope tag (as BBa_K562018). This will allow better monitoring of production of the protein. Indeed, we could detect production of this fusion in E. coli using an anti-HA monoclonal antibody. We did not get the chance to test arsenic resistance in a host cell producing this part. |
UNIQafaeea44a76f2942-partinfo-00000004-QINU